Latency and reactivation of human cytomegalovirus.

The sequence analysis of herpesviruses suggests they have been evolving with their individual vertebrate hosts for millions of years, and their divergence parallels that of the hosts they infect. Given this time they have been learning to live with their individual hosts, it is not surprising that they have become extremely well adapted to doing so without causing much in the way of obvious disease. A key feature of their strategy for persisting in the host is the ability of all herpesviruses to establish latent infection-a state in which no, or only a very limited set of, viral genes are expressed in cells in which viral DNA persists. The alpha herpesviruses (herpes simplex and varicella zoster virus) establish latency in neuronal cells in sensory ganglia: these are long lived non-dividing cells and the alpha herpesviruses persist in these with expression of only the latency associated transcripts-although the function of these RNA transcripts remains incompletely understood. The principal gamma herpesvirus of humans, Epstein Barr virus (EBV), is latent mainly in B lymphocytes: EBV persistence in B cells is associated with expression of a limited set of viral genes encoding functions necessary for the maintenance of the episomal viral DNA as B cells divide.The mechanism by which the principal beta herpesvirus of humans-human cytomegalovirus (HCMV) persists, is also incompletely understood and the subject of this review. Understanding how HCMV persists has clinical relevance in that its transmission to seronegative recipients might be more easily prevented, and the mechanisms by which it produces disease in the neonate and immunocompromised hosts more easily understood, if we knew more about the cells in which the virus is latent and the way in which it reactivates.

[1]  J. Sinclair,et al.  Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. , 1996, The Journal of general virology.

[2]  F. Goodrum,et al.  Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: A model for latency , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Soligo,et al.  Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells , 2001, British journal of haematology.

[4]  J. Sissons,et al.  Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses , 1988, The Journal of experimental medicine.

[5]  S. Khorasanizadeh The Nucleosome From Genomic Organization to Genomic Regulation , 2004, Cell.

[6]  F. Goodrum,et al.  Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. , 2004, Blood.

[7]  P. Ghazal,et al.  Interactions between cellular regulatory proteins and a unique sequence region in the human cytomegalovirus major immediate-early promoter. , 1990, Virology.

[8]  J. Danesh Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies. , 1999, American heart journal.

[9]  J Baillie,et al.  The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells. , 1991, Nucleic acids research.

[10]  J. Nelson,et al.  Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. , 1985, Science.

[11]  M. Ehrlich,et al.  Three MDBP sites in the immediate-early enhancer-promoter region of human cytomegalovirus. , 1991, Virology.

[12]  P. Tsichlis,et al.  repressor . binds DNA and functions as a transcriptional Gfi-1 encodes a nuclear zinc finger protein , 1996 .

[13]  J. Scott,et al.  Infection and reactivation with cytomegalovirus strains in lung transplant recipients. , 1991, Transplantation.

[14]  J. Xu,et al.  Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Burton,et al.  The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. , 1992, Journal of immunology.

[16]  L. M. Rocha,et al.  Evaluation of the host transcriptional response to human cytomegalovirus infection. , 2004, Physiological genomics.

[17]  G. Wilkinson,et al.  NF‐kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. , 1989, The EMBO journal.

[18]  G. Hayward,et al.  Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian and murine cytomegalovirus. , 1988, The Journal of general virology.

[19]  J. Sinclair,et al.  Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers , 1994, Journal of virology.

[20]  Michael Boshart,et al.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus , 1985, Cell.

[21]  C. B. Toorkey,et al.  Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues. , 1989, The Journal of infectious diseases.

[22]  B. Sugden,et al.  EBNA‐1: a protein pivotal to latent infection by Epstein–Barr virus , 2000, Reviews in medical virology.

[23]  A. Lusser Acetylated, methylated, remodeled: chromatin states for gene regulation. , 2002, Current opinion in plant biology.

[24]  P Ghazal,et al.  Cell-specific activity of the modulator region in the human cytomegalovirus major immediate-early gene , 1989, Molecular and cellular biology.

[25]  G. Rice,et al.  Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Bloom,et al.  Specific Histone Tail Modification and Not DNA Methylation Is a Determinant of Herpes Simplex Virus Type 1 Latent Gene Expression , 2004, Journal of Virology.

[27]  D. Spector Activation and regulation of human cytomegalovirus early genes. , 1996, Intervirology.

[28]  Jonathan W. Heusel,et al.  Vital Involvement of a Natural Killer Cell Activation Receptor in Resistance to Viral Infection , 2001, Science.

[29]  X. Jin,et al.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL , 1996, Journal of virology.

[30]  A. Verdel,et al.  Functional significance of histone deacetylase diversity. , 2001, Current opinion in genetics & development.

[31]  M. Stinski,et al.  Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells , 1997, Journal of virology.

[32]  J. Sissons,et al.  Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. , 1993, The Journal of general virology.

[33]  D. Taylor,et al.  Detection of human cytomegalovirus in peripheral mononuclear cells and urine samples using PCR. , 1992, Molecular and cellular probes.

[34]  C. Alford,et al.  Breast Milk and the Risk of Cytomegalovirus Infection , 1981, The New England journal of medicine.

[35]  A. Adams Replication of latent Epstein-Barr virus genomes in Raji cells , 1987, Journal of virology.

[36]  C. Prober,et al.  Prevention of transfusion-acquired cytomegalovirus infections in newborn infants , 1981 .

[37]  Beatrix Ueberheide,et al.  Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. , 2003, Molecular cell.

[38]  L. Hertel,et al.  Susceptibility of Immature and Mature Langerhans Cell-Type Dendritic Cells to Infection and Immunomodulation by Human Cytomegalovirus , 2003, Journal of Virology.

[39]  W. Britt,et al.  Human cytomegalovirus glycoproteins. , 1996, Intervirology.

[40]  M. Greaves,et al.  Identification of a membrane glycoprotein associated with haemopoietic progenitor cells. , 1985, Leukemia research.

[41]  W. Halford,et al.  ICP0 Is Required for Efficient Reactivation of Herpes Simplex Virus Type 1 from Neuronal Latency , 2001, Journal of Virology.

[42]  S. Stenglein,et al.  Efficient Lytic Infection of Human Arterial Endothelial Cells by Human Cytomegalovirus Strains , 2000, Journal of Virology.

[43]  E. Mocarski,et al.  Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Dieter Lang,et al.  Analysis of proteins binding to the proximal promoter region of the human cytomegalovirus IE-1/2 enhancer/promoter reveals both consensus and aberrant recognition sequences for transcription factors Sp1 and CREB , 1992, Nucleic Acids Res..

[45]  M. Weekes,et al.  Identification of Naive or Antigen-Experienced Human CD8+ T Cells by Expression of Costimulation and Chemokine Receptors: Analysis of the Human Cytomegalovirus-Specific CD8+ T Cell Response1 , 2002, The Journal of Immunology.

[46]  B. Weinshenker,et al.  Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. , 1988, Journal of immunology.

[47]  M. Weekes,et al.  Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells. , 1999, Journal of immunology.

[48]  K. Fish,et al.  Reactivation of Latent Human Cytomegalovirus in CD14+ Monocytes Is Differentiation Dependent , 2001, Journal of Virology.

[49]  Carlos Lopez,et al.  Human Herpesviruses: List of contributors , 2007 .

[50]  T. Finkel,et al.  The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus , 1996, The Lancet.

[51]  A. Bitsch,et al.  Failure to detect human cytomegalovirus DNA in peripheral blood leukocytes of healthy blood donors by the polymerase chain reaction , 1992, Transfusion.

[52]  M. Stinski,et al.  Regulation of human cytomegalovirus immediate-early gene expression. , 1996, Intervirology.

[53]  J. Sissons,et al.  Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo. , 2004, The Journal of general virology.

[54]  E. Matutes,et al.  The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. , 1989, Experimental hematology.

[55]  J. Sissons,et al.  Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow , 1994, Journal of virology.

[56]  F. Hufert,et al.  Infection of blood and bone marrow cells with the human cytomegalovirus in vivo. , 1997, Leukemia & lymphoma.

[57]  P. Becker,et al.  Histone acetylation: a switch between repressive and permissive chromatin , 2002, EMBO reports.

[58]  M. Pizzorno Nuclear cathepsin B-like protease cleaves transcription factor YY1 in differentiated cells. , 2001, Biochimica et biophysica acta.

[59]  M. Weekes,et al.  The Memory Cytotoxic T-Lymphocyte (CTL) Response to Human Cytomegalovirus Infection Contains Individual Peptide-Specific CTL Clones That Have Undergone Extensive Expansion In Vivo , 1999, Journal of Virology.

[60]  J. Virelizier,et al.  Latently Infected Thp-1 Monocytes Receptor Gene Us28 Is Transcribed in Human Cytomegalovirus Chemokine , 2000 .

[61]  Markus Wagner,et al.  Human Cytomegalovirus UL131-128 Genes Are Indispensable for Virus Growth in Endothelial Cells and Virus Transfer to Leukocytes , 2004, Journal of Virology.

[62]  J. Meier,et al.  The Human Cytomegalovirus Major Immediate-Early Distal Enhancer Region Is Required for Efficient Viral Replication and Immediate-Early Gene Expression , 2000, Journal of Virology.

[63]  J. Sinclair,et al.  Latent and persistent infections of monocytes and macrophages. , 1996, Intervirology.

[64]  J. Nelson,et al.  Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. , 1988, The American journal of pathology.

[65]  M. Jordan Latent infection and the elusive cytomegalovirus. , 1983, Reviews of infectious diseases.

[66]  T. Lazzarotto,et al.  Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[67]  S. Jonjić,et al.  Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection , 1998, The Journal of experimental medicine.

[68]  H. Ploegh,et al.  Cytomegaloviruses use multiple mechanisms to elude the host immune response. , 1997, Immunology letters.

[69]  E. Seto,et al.  Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? , 1999, Gene.

[70]  P. Ghazal,et al.  Human cytomegalovirus productively infects primary differentiated macrophages , 1991, Journal of virology.

[71]  E. Mocarski,et al.  Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[72]  B. Slobedman,et al.  A Novel Viral Transcript with Homology to Human Interleukin-10 Is Expressed during Latent Human Cytomegalovirus Infection , 2004, Journal of Virology.

[73]  P. Andrews,et al.  Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. , 1984, Science.

[74]  J. Meier Reactivation of the Human Cytomegalovirus Major Immediate-Early Regulatory Region and Viral Replication in Embryonal NTera2 Cells: Role of Trichostatin A, Retinoic Acid, and Deletion of the 21-Base-Pair Repeats and Modulator , 2001, Journal of Virology.

[75]  P. Ghazal,et al.  Regulation and tissue-specific expression of human cytomegalovirus. , 1990, Current topics in microbiology and immunology.

[76]  L. Picker,et al.  Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. , 2002, The Journal of infectious diseases.

[77]  A. Colberg-Poley Functional roles of immediate early proteins encoded by the human cytomegalovirus UL36-38, UL115-119, TRS1/IRS1 and US3 loci. , 1996, Intervirology.

[78]  H. Einsele,et al.  Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. , 2000, The Journal of general virology.

[79]  W. Drew,et al.  Diagnosis of cytomegalovirus infection. , 1988, Reviews of infectious diseases.

[80]  R. Everett ICP0, a regulator of herpes simplex virus during lytic and latent infection. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[81]  Gioacchino Natoli,et al.  Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. , 2002, Genes & development.

[82]  T. Raju,et al.  Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis. , 1985, The Journal of pediatrics.

[83]  A. Gouw,et al.  Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. , 1995, The Journal of general virology.

[84]  M. Reddehase The immunogenicity of human and murine cytomegaloviruses. , 2000, Current Opinion in Immunology.

[85]  J. Sissons,et al.  Repression of human cytomegalovirus gene expression associated with a novel immediate early regulatory region binding factor. , 1989, Nucleic acids research.

[86]  T. Hamilton,et al.  Molecular Transductional Mechanisms by which IFNγ and Other Signals Regulate Macrophage Development , 1987, Immunological reviews.

[87]  K. Fish,et al.  Reactivation of Latent Human Cytomegalovirus by Allogeneic Stimulation of Blood Cells from Healthy Donors , 1997, Cell.

[88]  M. Prevost,et al.  Human cytomegalovirus infection of bone marrow myofibroblasts enhances myeloid progenitor adhesion and elicits viral transmission. , 2001, Microbes and infection.

[89]  Stephen Rea,et al.  Central role of Drosophila SU(VAR)3–9 in histone H3‐K9 methylation and heterochromatic gene silencing , 2002, The EMBO journal.

[90]  P. Farrell,et al.  Histone Acetylation and Reactivation of Epstein-Barr Virus from Latency , 2000, Journal of Virology.

[91]  G. Hayward,et al.  Constitutive and retinoic acid-inducible expression of cytomegalovirus immediate-early genes in human teratocarcinoma cells , 1986, Journal of virology.

[92]  S. Riddell,et al.  Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes , 1994, Journal of medical virology.

[93]  S. Saccani,et al.  p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.

[94]  Andrew J. Bannister,et al.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain , 2001, Nature.

[95]  E. Fortunato,et al.  Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. , 2000, Trends in microbiology.

[96]  R. Rabinovich,et al.  Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[97]  D. Metcalf,et al.  The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells , 1989, Nature.

[98]  E. Mocarski,et al.  Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. , 1999, Blood.

[99]  J. Nelson,et al.  Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene , 1987, Molecular and cellular biology.

[100]  J. Maciejewski,et al.  Human cytomegalovirus infection of human hematopoietic progenitor cells. , 1999, Leukemia & lymphoma.

[101]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[102]  S. Larsson,et al.  Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time , 1998, Transfusion.

[103]  J. Sinclair,et al.  Ets-2 Repressor Factor (ERF) mediates repression of the human cytomegalovirus major immediate-early promoter in undifferentiated non-permissive cells. , 2003, The Journal of general virology.

[104]  M. van der Giessen,et al.  Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. , 1993, The Journal of infectious diseases.

[105]  B. Plachter,et al.  Tissue macrophages are infected by human cytomegalovirus in vivo. , 1996, The Journal of infectious diseases.

[106]  E. Mocarski,et al.  Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. , 2002, Blood.

[107]  R. Rubin Impact of cytomegalovirus infection on organ transplant recipients. , 1990, Reviews of infectious diseases.

[108]  T. Gingeras,et al.  Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[109]  S. Adler Transfusion-associated cytomegalovirus infections. , 1983, Reviews of infectious diseases.

[110]  E. Mocarski,et al.  Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. , 1995, Scandinavian journal of infectious diseases. Supplementum.

[111]  W. Britt,et al.  A novel mechanism for persistence of human cytomegalovirus in macrophages , 1996, Journal of virology.

[112]  W. Britt,et al.  A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. , 1999, The Journal of infectious diseases.

[113]  T. The,et al.  Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products , 1989, Transfusion.

[114]  N. Sawtell The Probability of In Vivo Reactivation of Herpes Simplex Virus Type 1 Increases with the Number of Latently Infected Neurons in the Ganglia , 1998, Journal of Virology.

[115]  V. Goldmacher Cell death suppressors encoded by cytomegalovirus. , 2004, Progress in molecular and subcellular biology.

[116]  E. Mocarski,et al.  Human Cytomegalovirus Latency-Associated Protein pORF94 Is Dispensable for Productive and Latent Infection , 2000, Journal of Virology.

[117]  M. Jarvis,et al.  Mechanisms of human cytomegalovirus persistence and latency. , 2002, Frontiers in bioscience : a journal and virtual library.

[118]  J. Bell,et al.  Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+ T Lymphocytes in Healthy Seropositive Donors , 2000, Journal of Virology.

[119]  J. Wiedeman,et al.  Latency-associated sense transcripts are expressed during in vitro human cytomegalovirus productive infection. , 2000, Virology.

[120]  C. Bruggeman,et al.  Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. , 1997, Journal of clinical pathology.

[121]  David C. Johnson,et al.  Herpesvirus evasion of the immune system. , 1998, Current topics in microbiology and immunology.

[122]  M. Groudine,et al.  Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites , 1986, Molecular and cellular biology.

[123]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[124]  W. Britt,et al.  Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. , 1991, Journal of immunology.

[125]  C. Allis,et al.  Roles of histone acetyltransferases and deacetylases in gene regulation , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[126]  H. Einsele,et al.  Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. , 1999, The Journal of general virology.

[127]  S. Spector,et al.  Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages , 1991, Journal of virology.

[128]  A. Sinclair bZIP proteins of human gammaherpesviruses. , 2003, The Journal of general virology.

[129]  V. Connor,et al.  Herpes Simplex Virus Type 1 Promoter Activity during Latency Establishment, Maintenance, and Reactivation in Primary Dorsal Root Neurons In Vitro , 2001, Journal of Virology.

[130]  E Tom,et al.  Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains , 1996, Journal of virology.

[131]  T. Kowalik,et al.  Human cytomegalovirus immediate early proteins and cell growth control. , 2002, Gene.

[132]  J Baillie,et al.  Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line. , 1992, The Journal of general virology.

[133]  R. Welsh,et al.  Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo , 1985, The Journal of experimental medicine.

[134]  G. Hunninghake,et al.  The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements , 1989, Journal of virology.

[135]  J. Sissons,et al.  Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. , 1991, The Journal of general virology.

[136]  A. McMichael,et al.  Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. , 2000, Science.

[137]  T. Chatila,et al.  Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. , 1997, Trends in microbiology.

[138]  R. Stenberg The human cytomegalovirus major immediate-early gene. , 1996, Intervirology.

[139]  Ru Liu,et al.  The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells , 1994, Nucleic Acids Res..

[140]  K. Itakura,et al.  Repression by a differentiation-specific factor of the human cytomegalovirus enhancer. , 1996, Nucleic acids research.

[141]  B. Wahrén,et al.  Interferon induction in human leukocytes after in vitro exposure to cytomegalovirus or Epstein-Barr virus. , 1985, Intervirology.

[142]  E. Verdin,et al.  Control of cytomegalovirus lytic gene expression by histone acetylation , 2002, The EMBO journal.

[143]  A. Cunningham,et al.  Impact of Human Cytomegalovirus Latent Infection on Myeloid Progenitor Cell Gene Expression , 2004, Journal of Virology.

[144]  E. Mocarski,et al.  Quantitative Analysis of Latent Human Cytomegalovirus , 1999, Journal of Virology.

[145]  M. Groudine,et al.  Chromosomal subunits in active genes have an altered conformation. , 1976, Science.

[146]  H. Strobl Molecular Mechanisms of Dendritic Cell Sublineage Development from Human Hematopoietic Progenitor/Stem Cells , 2003, International Archives of Allergy and Immunology.

[147]  J. Nelson,et al.  Models of HCMV latency and reactivation. , 2003, Trends in microbiology.